MA44057A - Produit combiné - Google Patents
Produit combinéInfo
- Publication number
- MA44057A MA44057A MA044057A MA44057A MA44057A MA 44057 A MA44057 A MA 44057A MA 044057 A MA044057 A MA 044057A MA 44057 A MA44057 A MA 44057A MA 44057 A MA44057 A MA 44057A
- Authority
- MA
- Morocco
- Prior art keywords
- combined product
- combined
- product
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1522232.6A GB201522232D0 (en) | 2015-12-16 | 2015-12-16 | Combination product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA44057A true MA44057A (fr) | 2018-10-24 |
Family
ID=55274872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA044057A MA44057A (fr) | 2015-12-16 | 2016-12-16 | Produit combiné |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10799494B2 (fr) |
| EP (1) | EP3389659A1 (fr) |
| CN (1) | CN108697705A (fr) |
| GB (1) | GB201522232D0 (fr) |
| MA (1) | MA44057A (fr) |
| WO (1) | WO2017103615A1 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018084809A1 (fr) * | 2016-11-02 | 2018-05-11 | Nanyang Technological University | Méthodes permettant le traitement ou la prévention d'infections mycobactériennes |
| WO2019055528A1 (fr) | 2017-09-13 | 2019-03-21 | Cerepeut, Inc. | Nouveau composé à petites molécules |
| EP3897651A4 (fr) * | 2018-12-21 | 2022-09-21 | University of Notre Dame du Lac | Découverte d'inhibiteurs de la bd oxydase pour le traitement de maladies mycobactériennes |
| KR20220071199A (ko) * | 2019-09-30 | 2022-05-31 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 4-퀴놀리논 항균 화합물 |
| MX2022003816A (es) | 2019-09-30 | 2022-05-06 | Janssen Sciences Ireland Unlimited Co | Compuestos antibacterianos. |
| CN115380029B (zh) * | 2019-11-26 | 2025-06-17 | 南洋理工大学 | 用于治疗结核病的化合物 |
| MX2022006865A (es) | 2019-12-06 | 2022-07-11 | Vertex Pharma | Tetrahidrofuranos sustituidos como moduladores de canales de sodio. |
| WO2022214519A1 (fr) | 2021-04-07 | 2022-10-13 | Janssen Sciences Ireland Unlimited Company | Composés antibactériens |
| WO2022214520A1 (fr) | 2021-04-07 | 2022-10-13 | Janssen Sciences Ireland Unlimited Company | Composés antibactériens |
| CN117794920A (zh) | 2021-06-04 | 2024-03-29 | 沃泰克斯药物股份有限公司 | N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂 |
| DK4426434T3 (da) | 2021-11-02 | 2025-11-10 | Flare Therapeutics Inc | Pparg inverse agonists and uses thereof |
| JP2025513455A (ja) | 2022-04-22 | 2025-04-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | 疼痛の治療のためのヘテロアリール化合物 |
| CN117883436B (zh) * | 2023-11-29 | 2025-05-02 | 中国科学院深圳先进技术研究院 | 内过氧化合物单用或与呼吸链抑制剂联用在制备抗菌药物中的用途、抗菌药物 |
| WO2025111889A1 (fr) * | 2023-11-29 | 2025-06-05 | 中国科学院深圳先进技术研究院 | Utilisation d'endoperoxyde seul ou en combinaison avec un inhibiteur de la chaîne respiratoire dans la préparation d'un médicament antibactérien, et médicament antibactérien et son utilisation dans le traitement de la tuberculose |
| CN118453579A (zh) * | 2024-03-30 | 2024-08-09 | 中国科学院深圳先进技术研究院 | 抗结核分枝杆菌组合物及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201020076D0 (en) * | 2010-11-26 | 2011-01-12 | Liverpool School Tropical Medicine | Antimalarial compounds |
-
2015
- 2015-12-16 GB GBGB1522232.6A patent/GB201522232D0/en not_active Ceased
-
2016
- 2016-12-16 EP EP16822230.5A patent/EP3389659A1/fr active Pending
- 2016-12-16 MA MA044057A patent/MA44057A/fr unknown
- 2016-12-16 CN CN201680081942.4A patent/CN108697705A/zh active Pending
- 2016-12-16 US US16/062,443 patent/US10799494B2/en active Active
- 2016-12-16 WO PCT/GB2016/053972 patent/WO2017103615A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017103615A1 (fr) | 2017-06-22 |
| US20190151305A1 (en) | 2019-05-23 |
| CN108697705A (zh) | 2018-10-23 |
| EP3389659A1 (fr) | 2018-10-24 |
| US10799494B2 (en) | 2020-10-13 |
| GB201522232D0 (en) | 2016-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3292156C0 (fr) | Produit cellulosique nanofibrillaire | |
| EP3357488A4 (fr) | Produit cosmétique | |
| EP3338592A4 (fr) | Produit cosmétique | |
| EP3332763A4 (fr) | Produit cosmétique | |
| BR112016019110A2 (pt) | Dispensador | |
| EP3460016A4 (fr) | Produit stratifié | |
| EP3403642A4 (fr) | Produit cosmétique | |
| SI3356264T1 (sl) | Postopek za razporejanje izdelkov | |
| EP3456311A4 (fr) | Produit cosmétique | |
| DK3508196T3 (da) | Aripiprazol-prodrugsammensætninger | |
| EP3449898A4 (fr) | Produit cosmétique | |
| EP3357686A4 (fr) | Produit décoratif métallique | |
| EP3509544A4 (fr) | Produit orthétique | |
| FR3044643B1 (fr) | Produit alimentaire emballe | |
| EP3217965C0 (fr) | Proces pharmaceutique | |
| EP3527089A4 (fr) | Produit de jambe | |
| EP3482652A4 (fr) | Produit cosmétique | |
| DK3307076T3 (da) | Podepartikelprodukt | |
| PL3539401T3 (pl) | Połączony wyrób tekstylny | |
| EP3417249A4 (fr) | Détecteur de produit | |
| EP3320781A4 (fr) | Produit laitier | |
| DK3182958T4 (da) | Aripiprazol-prodrugsammensætninger | |
| EP3530120A4 (fr) | Article de confiserie | |
| FR3028721B3 (fr) | Produit alimentaire | |
| FR3019990B3 (fr) | Produit medical |